EC-0225

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEC-0225
Drug Alias NameDAVLBH and mitomycin-C conjugateDesacetylvinblastine hydrazide and mitomycin-C conjugateEC-0225
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsTubulin inhibitorsMitosis inhibitors +[5] 
TargetsTubulinDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocyte Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A